We are happy to announce that the paper of our clinical trial in patients with a Barrett’s Oesophagus is published online in the journal Gut, a leading international journal in gastroenterology and hepatology (2016 impact factor: 16.658) We would like to thank all the co-autors, patients and collaborateurs that made this trial to a great succes. The fullRead more →
Recently we started a phase II-b multicenter study that aims to further characterize the performance of EMI-137, a fluorescent compound targeting c-Met, for detection of dysplastic colorectal polyps during colonoscopy. In this study, patients with a high suspicion of colorectal cancer (CRC) that are scheduled to undergo a colonoscopy will be enrolled. Study patients willRead more →
Wednesday November 29th Elmire Hartmans successfully defended her PhD thesis and subsequently got her PhD degree. Congratulations!Read more →
The collaboration with Rudolf Fehrmann has led to a publication in Journal of Nuclear Medicine. We used functional genomic mRNA profiling to identify novel targets for theranostic approaches in pancreatic cancer. The manuscript can be viewed here: https://www.ncbi.nlm.nih.gov/pubmed/29051346 Data driven prioritization and review of targets for molecular based theranostic approaches in pancreatic cancer. Koller M, Hartmans E,Read more →